Stephanie Pfaender

Junior Professor

Ruhr-Universität Bochum

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stephanie Pfaender is a Junior Professor at Ruhr University Bochum in Germany. Her research focuses on viral interactions and cellular responses, particularly in the context of SARS-CoV-2 and COVID-19. Recent articles include investigations into mycophenolic acid treatment effects, mitochondrial transcription factors, and potential drug targets for lung diseases. She contributes to advancing understanding of both antiviral mechanisms and the immune response to viral infections.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Tran Tuoc

Ruhr-Universität Bochum

GERMANY

View details

Philip V'kovski

University of Bern

SWITZERLAND

View details

Eike Steinmann

Ruhr-Universität Bochum

GERMANY

View details

Jürgen Knobloch

Laboratory Head, Group Leader

GERMANY

View details

Simon Schroeder

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephanie Pfaender

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants

Ultra‐Shallow Flat Heat Waves on Low Thermal Conductivity Flexible Polyimide Substrate for Millisecond Thermal Analysis of Materials and Bioelectronic Applications

The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19

Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases

MicroRNAs modulate SARS‐CoV infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2

Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity

Divergent autoantibody and cytokine levels in COVID‐19 sepsis patients influence survival

Editorial overview: Coronaviruses 2024

The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle

Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.

Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols.

Temperature-dependent surface stability of SARS-CoV-2

Corrigendum to "Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents" [J Hosp Infect 104 (2020) 246-251

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

Collaborators (5)

Tran Tuoc

Philip V'kovski

Eike Steinmann

Jürgen Knobloch

Simon Schroeder

Make your next move.